TAK — TAKEDA PHARMACEUTICAL CO LTD
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-12-24.
Performance
Technicals
Dividends
Measured signals that fired on TAK
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-08-06 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-04 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-21 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-09 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-02 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-19 | Plump Andrew Stewart President, R&D | Open-market sale 10b5-1 plan | 19.7K | 18.49 | 363.3K |
| 2026-08-18 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Open-market sale | 13.0K | 18.11 | 235.1K |
| 2026-08-11 | Shannon Elaine Mary Pres., Global Supply & Quality | Open-market sale | 20.4K | 17.55 | 357.4K |
| 2026-08-10 | Plump Andrew Stewart President, R&D | Open-market sale | 165.4K | 17.10 | 2.8M |
| 2026-08-10 | Kim Julie So-Young President and CEO | Open-market sale | 89.1K | 17.10 | 1.5M |
| 2026-08-10 | Bitetti Teresa Marie President, OBU | Open-market sale | 50.0K | 17.10 | 855.2K |
| 2026-08-10 | Duprey Lauren Rusckowski Chief Transformation Officer | Open-market sale | 47.6K | 17.10 | 813.7K |
| 2026-08-10 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Open-market sale | 33.6K | 17.51 | 588.7K |
| 2026-08-10 | Platford Giles Richard President, IBU | Open-market sale | 31.1K | 17.10 | 531.5K |
| 2026-08-10 | Furney Natalie Anne Marie Global General Counsel | Open-market sale | 30.9K | 17.10 | 527.8K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Capital Research Global Investors | 353.8M | 19.1M |
| FMR LLC | 131.8M | 7.1M |
| MORGAN STANLEY | 119.8M | 6.5M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 119.0M | 6.4M |
| GOLDMAN SACHS GROUP INC | 104.1M | 5.6M |
| BRANDES INVESTMENT PARTNERS, LP | 82.1M | 4.4M |
| BlackRock, Inc. | 58.8M | 3.2M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 57.7M | 3.1M |
| RENAISSANCE TECHNOLOGIES LLC | 55.4M | 3.0M |
| UBS Group AG | 50.7M | 2.7M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 144 | 2026-08-14 | — | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
Others in Healthcare
Ask the AI about TAK
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →